...
首页> 外文期刊>Drugs of the Future >TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - AN AACR CONFERENCE BOSTON, MASSACHUSETTS, USA - OCTOBER 20-23, 2016
【24h】

TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - AN AACR CONFERENCE BOSTON, MASSACHUSETTS, USA - OCTOBER 20-23, 2016

机译:肿瘤免疫学和免疫疗法-美国麻萨诸塞州波士顿市会议,2016年10月20-23日

获取原文
获取原文并翻译 | 示例

摘要

The field of immune-oncology is rapidly progressing with new data being generated across all research areas of this field. The American Association for Cancer Research (AACR)'s Tumor Immunology and Immunotherapy meeting, the sixth in this series, provides a forum for researchers from academia and industry, as well as clinicians, to present their work to a global audience to enhance the understanding of the immune response to cancer and to focus on how this response can be used for disease treatment and prevention.
机译:免疫肿瘤学领域正在迅速发展,正在该领域所有研究领域中产生新数据。美国癌症研究协会(AACR)的肿瘤免疫学和免疫疗法会议,本系列的第六次会议,为学术界和工业界的研究人员以及临床医生提供了一个论坛,向全球观众介绍他们的工作,以增进了解对癌症的免疫反应的研究,并着重于如何将这种反应用于疾病的治疗和预防。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号